H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Microbot Medical today and set a price target of $12.00. The company’s shares closed last Monday at $2.35. According to TipRanks.com, ...

I’m already loving this device, and I haven’t even touched one. Arduino announced it has collaborated with M5Stack to develop the new compact and powerful Nesso N1 IoT development kit. This system ...

This is read by an automated voice. Please report any issues or inconsistencies here. Peter Jackson, the visionary filmmaker who adapted author J.R.R. Tolkien’s epic fantasy for the big screen in the ...

It’s been a wild week to be a fan of Buffy the Vampire Slayer. On March 14, Buffy Summers herself (Sarah Michelle Gellar) took to Instagram to deliver news that felt like a stake to the heart. A ...

Sarah Michelle Gellar has asked fans not to read a leaked version of the Buffy the Vampire Slayer reboot script, and emphasized that the project was still a work-in-progress at the time of its ...

GameSpot may get a commission from retail offers. When Barbarian and Weapons director Zach Cregger signed on to helm the next Resident Evil movie, it was described as "a revamp that will take the ...

What if you could combine the simplicity of Arduino with the power of a Linux-based processor, all in one compact device? Enter the Arduino Uno Q, a new development board designed to handle everything ...

Fintel reports that on December 3, 2025, Roth Capital initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 453.85% Upside As of November 17 ...

Some members of the maker community are distraught about Arduino’s new terms of service (ToS), saying that the added rules put the company’s open source DNA at ...

Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

Morris Chapdelaine always has a daunting stack of scripts on his desk. As an indie producer, he reads about three a week and farms out the rest to interns and film students, who send back detailed ...